Clinical Trials on Metabolites
Total 30 results
-
University of HelsinkiSamfundet Folkhälsan; Sigrid Jusélius FoundationCompletedKinetics of Alkylresorcinol MetabolitesFinland
-
BrightseedUniversity of Arkansas; Biofortis Mérieux NutriSciencesActive, not recruiting
-
University of Massachusetts, AmherstCompleted
-
Glac Biotech Co., LtdCompletedProbiotics | Oral Health | Probiotic MetabolitesTaiwan
-
Columbia UniversityCompletedArsenic Metabolites Measured in UrineBangladesh
-
Rennes University HospitalRecruitingBlood Concentration of Tacrolimus MetabolitesFrance
-
USDA Beltsville Human Nutrition Research CenterWithdrawnFocus is Understanding Absorption of Garlic MetabolitesUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of Darexaban and MetabolitesFrance
-
Northumbria UniversityInternational Nut and Dried Fruit CouncilCompletedCognitive Function | Intestinal Microbiota | Urinary MetabolitesUnited Kingdom
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of Darexaban and MetabolitesFrance
-
Factors Group of Nutritional Companies Inc.IsuraCompletedPhase I and Phase II Metabolites of BerberineCanada
-
Medical University of GdanskNational Science Centre, PolandActive, not recruitingStress-induced Mood | Kynurenine Pathway and Its MetabolitesPoland
-
Chang Gung Memorial HospitalCompletedNeurodegenerative Diseases | Aging | MetabolitesTaiwan
-
Bristol-Myers SquibbCompletedMetabolicsUnited States
-
AstraZenecaCompletedCYP2C19 Poor | Extensive MetabolizersTaiwan
-
Shenzhen People's HospitalShenzhen Bao'an Maternal and Child Health Hospital; Longgang Maternal and Child...Not yet recruitingGut Microbiota | MetabolitesChina
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedPoor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 VariantBrazil
-
Primex Clinical Laboratories, Inc.Research & Development Institute, Inc.UnknownPatients on Medications Metabolized Via CYP450United States
-
Poitiers University HospitalCompletedDiurnal Variations of Cerebral MetaboliteFrance
-
University of GroningenZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedDepressive Disorder | Depression | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant | Intermediate Metabolizer Due to Cytochrome P450 CYP2D6 VariantNetherlands
-
International Agency for Research on CancerUniversidad de Murcia; Federico II University; University of Tromso; Imperial College... and other collaboratorsCompletedNo Condition, Focus: Metabolites of Alcohol Consumption
-
Nanfang Hospital, Southern Medical UniversityRecruitingHead and Neck Cancer | MetaboliteChina
-
Karolinska InstitutetKarolinska University HospitalRecruitingRenal Failure | Acute Kidney Injury | Pharmacokinetics | Intensive Care | MetabolitesSweden
-
AstraZenecaCompletedAsthma, | Pharmacokinetics, | Cmax, | Tmax, | λz, | AUC, | Ketoconazole, | MetaboliteUnited Kingdom
-
Genelex CorporationUniversity of UtahCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme Deficiency | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome... and other conditionsUnited States
-
Genelex CorporationCompletedDrug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 CYP2D6 Enzyme Deficiency | Cytochrome P450 CYP2C9 Enzyme Deficiency | Cytochrome P450 CYP2C19 Enzyme Deficiency | Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant | CYP2D6 Polymorphism | Ultrarapid... and other conditionsUnited States
-
Genelex CorporationHarding UniversityCompletedDrug Interaction Potentiation | Adverse Drug Events | Adverse Drug Reactions | Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant | Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant | Drug Metabolism, Poor, CYP2D6-RELATED | Drug Metabolism, Poor, CYP2C19-RELATED | Cytochrome P450 Enzyme... and other conditionsUnited States
-
National Taiwan University HospitalUnknownPulmonary Function | Pulse Spectrum Analysis | FeNO | MetabolitesTaiwan
-
Nanfang Hospital of Southern Medical UniversityRecruitingHemorrhagic Stroke | Gut Microbiota | Outcomes | Acute | MetabolitesChina
-
Bristol-Myers SquibbCompletedMetabolics Diabetes NosUnited States, Spain, Argentina, Brazil, Germany, Mexico, Peru, Puerto Rico, Australia, Canada, Russian Federation, United Kingdom, France, Italy, Netherlands